Search Results 1101-1110 of 16022 for melatonin receptor agonists

  1. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

    About this study. This randomized phase III trial studies oxaliplatin, leucovorin calcium, fluorouracil, and bevacizumab to see how well they work compared ...

  2. Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI - Mayo Clinic

    Epidermal growth factor receptor (eGFR) should be above 30 within 30 days the time of mpMRI. Participating Mayo Clinic locations. Study statuses change often ...

  3. Antidepressants for children and teens - Mayo Clinic

    Antidepressant drugs are often an effective way to treat depression and anxiety in children and teenagers. However, antidepressant use in children and teens ...

  4. A Study of Self-reported Outcomes in Patients with Multiple Sclerosis (MS) - Mayo Clinic

    The purpose of this study is to determine clinical outcome following treatment for multiple sclerosis (MS) relapse, in patients who were seen at Mayo Clinic.

  5. A Study of Sonidegib and Pembrolizumab in Advanced Solid Tumors - Mayo Clinic

    About this study. The purpose of this study is to determine the maximum tolerated dose (MTD) of sonidegib in combination with pembrolizumab in participants ...

  6. Pentostatin (intravenous route) - Mayo Clinic

    Pentostatin belongs to the group of medicines called antimetabolites. It is used to treat a type of cancer of the white blood cells called hairy cell leukemia.

  7. Integrated Assessment of Gastric Functions - Mayo Clinic

    Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may affect central processing of pain. Positive tissue transglutaminase antibodies ...

  8. A Study to Evaluate Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol) - Mayo Clinic

    This National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studies how well a combination of different biomarker/ALK inhibitors work in treating ...

  9. Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) - Mayo Clinic

    Histological or cytological diagnosis of Stage IV NSCLC lacking epidermal growth factor receptor ... Receptor [TNFR] family), or anti-Cytotoxic T-lymphocyte- ...

  10. A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol - Mayo Clinic

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...